IPGSBOAMOORPHZ-GOSISDBHSA-N
C29H24F4N6O3 — CID 135337841
Data last refreshed: (MolForge compound catalog, from PubChem)
About IPGSBOAMOORPHZ-GOSISDBHSA-N
IPGSBOAMOORPHZ-GOSISDBHSA-N (PubChem CID 135337841) has the molecular formula C29H24F4N6O3 and a molecular weight of 580.54 g/mol. Its IUPAC name is 4-[3-[(3R)-1-but-2-ynoylpyrrolidin-3-yl]-5-ethoxyimidazo[1,5-a]pyrazin-1-yl]-3-fluoro-N-[4-(trifluoromethyl)-2-pyridinyl]benzamide.
Molecular Properties
| Compound Name | IPGSBOAMOORPHZ-GOSISDBHSA-N |
|---|---|
| PubChem CID | 135337841 |
| Molecular Formula | C29H24F4N6O3 |
| Molecular Weight | 580.54 g/mol |
| Exact Mass | 580.18 |
| IUPAC Name | 4-[3-[(3R)-1-but-2-ynoylpyrrolidin-3-yl]-5-ethoxyimidazo[1,5-a]pyrazin-1-yl]-3-fluoro-N-[4-(trifluoromethyl)-2-pyridinyl]benzamide |
| SMILES | CC#CC(=O)N1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3cncc(OCC)n23)C1 |
| InChI | InChI=1S/C29H24F4N6O3/c1-3-5-24(40)38-11-9-18(16-38)27-37-26(22-14-34-15-25(39(22)27)42-4-2)20-7-6-17(12-21(20)30)28(41)36-23-13-19(8-10-35-23)29(31,32)33/h6-8,10,12-15,18H,4,9,11,16H2,1-2H3,(H,35,36,41)/t18-/m1/s1 |
| InChIKey | IPGSBOAMOORPHZ-GOSISDBHSA-N |
| XLogP | 4.94 |
| TPSA | 101.72 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 580.54 |
| LogP ≤ 5 | 4.94 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135337841 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.